$RGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENXBIO Inc.. Get notifications about new insider transactions in REGENXBIO Inc. for free.
Page: < prev 1 2 3 4 5 6 ... 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 3,200 | 2,720 | 155,900 | ||
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 50.01 | 3,200 | 160,032 | 0 | 3.2 K to 0 (-100.00 %) | |
| Jan 21 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 3,200 | 2,720 | 3,200 | 0 to 3.2 K | |
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | M | 0.85 | 30,000 | 25,500 | 159,100 | ||
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Sell | S | 45.60 | 30,000 | 1,368,000 | 0 | 30 K to 0 (-100.00 %) | |
| Jan 16 2020 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Buy | M | 0.85 | 30,000 | 25,500 | 30,000 | 0 to 30 K | |
| Jan 10 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 3,000 | 39,270 | 29,374 | |
| Jan 10 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 41.92 | 5,100 | 213,792 | 224,715 | 229.8 K to 224.7 K (-2.22 %) |
| Jan 10 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 41.40 | 2,400 | 99,360 | 229,815 | 232.2 K to 229.8 K (-1.03 %) |
| Jan 10 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 3,000 | 39,270 | 232,215 | 229.2 K to 232.2 K (+1.31 %) |
| Jan 06 2020 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 38.99 | 48,000 | 1,871,520 | 48,000 | |
| Jan 06 2020 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 38.99 | 42,600 | 1,660,974 | 42,600 | |
| Jan 06 2020 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | A | 38.99 | 50,000 | 1,949,500 | 50,000 | |
| Dec 11 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 44.26 | 6,153 | 272,332 | 23,948 | 30.1 K to 23.9 K (-20.44 %) |
| Dec 11 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 43.40 | 9,399 | 407,917 | 30,101 | 39.5 K to 30.1 K (-23.79 %) |
| Sep 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 5,000 | 4,250 | 79,670 | |
| Sep 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 39.91 | 7,773 | 310,220 | 241,000 | 248.8 K to 241 K (-3.12 %) |
| Sep 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 39.19 | 2,227 | 87,276 | 248,773 | 251 K to 248.8 K (-0.89 %) |
| Sep 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 5,000 | 4,250 | 251,000 | 246 K to 251 K (+2.03 %) |
| Sep 16 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 39,931 | |
| Sep 16 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 42.00 | 5,486 | 230,412 | 2,572 | 8.1 K to 2.6 K (-68.08 %) |
| Sep 16 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 8,058 | 3.1 K to 8.1 K (+163.51 %) |
| Aug 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 84,670 | |
| Aug 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 37.92 | 376 | 14,258 | 246,000 | 246.4 K to 246 K (-0.15 %) |
| Aug 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 37.54 | 14,624 | 548,985 | 246,376 | 261 K to 246.4 K (-5.60 %) |
| Aug 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Jul 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 99,670 | |
| Jul 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 49.97 | 2,300 | 114,931 | 246,000 | 248.3 K to 246 K (-0.93 %) |
| Jul 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 49.40 | 12,700 | 627,380 | 248,300 | 261 K to 248.3 K (-4.87 %) |
| Jul 23 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 19.50 | 4,900 | 95,550 | 4,641 | |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 19.50 | 100 | 1,950 | 9,541 | |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 50.03 | 4,900 | 245,147 | 3,058 | 8 K to 3.1 K (-61.57 %) |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 19.50 | 4,900 | 95,550 | 7,958 | 3.1 K to 8 K (+160.24 %) |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 50.00 | 100 | 5,000 | 3,058 | 3.2 K to 3.1 K (-3.17 %) |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 19.50 | 100 | 1,950 | 3,158 | 3.1 K to 3.2 K (+3.27 %) |
| Jul 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Grant | A | 36.83 | 52 | 1,915 | 3,058 | 3 K to 3.1 K (+1.73 %) |
| Jun 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 114,670 | |
| Jun 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 53.25 | 4,120 | 219,390 | 246,000 | 250.1 K to 246 K (-1.65 %) |
| Jun 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 52.27 | 10,880 | 568,698 | 250,120 | 261 K to 250.1 K (-4.17 %) |
| Jun 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Jun 20 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 44,931 | |
| Jun 20 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 54.75 | 100 | 5,475 | 3,006 | 3.1 K to 3 K (-3.22 %) |
| Jun 20 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 53.29 | 1,934 | 103,063 | 3,106 | 5 K to 3.1 K (-38.37 %) |
| Jun 20 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 52.74 | 2,966 | 156,427 | 5,040 | 8 K to 5 K (-37.05 %) |
| Jun 20 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 8,006 | 3 K to 8 K (+166.33 %) |
| Jun 04 2019 | RGNX | REGENXBIO Inc. | Fox Allan M. | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | Tasse Daniel | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | STUMP DAVID C | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | KARABELAS ARGERIS N | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | HAYDEN DONALD J JR | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | Glucksmann Alexandra | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| Jun 04 2019 | RGNX | REGENXBIO Inc. | Abdun-Nabi Daniel | Option Exercise | A | 43.02 | 10,000 | 430,200 | 10,000 | ||
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 18,000 | 396,000 | 25,219 | |
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.00 | 18,000 | 900,000 | 39,500 | 57.5 K to 39.5 K (-31.30 %) |
| May 30 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 18,000 | 396,000 | 57,500 | 39.5 K to 57.5 K (+45.57 %) |
| May 22 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 129,670 | |
| May 22 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 43.99 | 300 | 13,197 | 246,000 | 246.3 K to 246 K (-0.12 %) |
| May 22 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 43.32 | 10,559 | 457,416 | 246,300 | 256.9 K to 246.3 K (-4.11 %) |
| May 22 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 42.08 | 4,141 | 174,253 | 256,859 | 261 K to 256.9 K (-1.59 %) |
| May 22 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 144,670 | |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 53.05 | 100 | 5,305 | 246,000 | 246.1 K to 246 K (-0.04 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 52.33 | 1,300 | 68,029 | 246,100 | 247.4 K to 246.1 K (-0.53 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 51.07 | 3,270 | 166,999 | 247,400 | 250.7 K to 247.4 K (-1.30 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 50.31 | 6,929 | 348,598 | 250,670 | 257.6 K to 250.7 K (-2.69 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 49.29 | 3,401 | 167,635 | 257,599 | 261 K to 257.6 K (-1.30 %) |
| Apr 24 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 19.50 | 1,459 | 28,451 | 9,641 | |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 3,541 | 42,846 | 49,931 | |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 55.50 | 100 | 5,550 | 3,006 | 3.1 K to 3 K (-3.22 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 54.66 | 885 | 48,374 | 3,106 | 4 K to 3.1 K (-22.17 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 53.67 | 1,115 | 59,842 | 3,991 | 5.1 K to 4 K (-21.84 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 52.55 | 2,900 | 152,395 | 5,106 | 8 K to 5.1 K (-36.22 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 19.50 | 1,459 | 28,451 | 8,006 | 6.5 K to 8 K (+22.29 %) |
| Apr 22 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 3,541 | 42,846 | 6,547 | 3 K to 6.5 K (+117.80 %) |
| Apr 19 2019 | RGNX | REGENXBIO Inc. | PAKOLA STEVE | Chief Medical Offic ... | Option Exercise | A | 54.72 | 95,000 | 5,198,400 | 95,000 | |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 2,000 | 40,700 | 71,500 | |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 53.09 | 1,000 | 53,090 | 6,500 | 7.5 K to 6.5 K (-13.33 %) |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 52.23 | 1,000 | 52,230 | 7,500 | 8.5 K to 7.5 K (-11.76 %) |
| Apr 17 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 2,000 | 40,700 | 8,500 | 6.5 K to 8.5 K (+30.77 %) |
| Mar 25 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 61.31 | 1,700 | 104,227 | 229,215 | 230.9 K to 229.2 K (-0.74 %) |
| Mar 25 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 60.64 | 8,300 | 503,312 | 230,915 | 239.2 K to 230.9 K (-3.47 %) |
| Mar 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 159,670 | |
| Mar 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 58.74 | 9,130 | 536,296 | 246,000 | 255.1 K to 246 K (-3.58 %) |
| Mar 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 58.21 | 5,870 | 341,693 | 255,130 | 261 K to 255.1 K (-2.25 %) |
| Mar 21 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Mar 14 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 5,000 | 101,750 | 73,500 | |
| Mar 14 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 5,000 | 101,750 | 6,500 | 1.5 K to 6.5 K (+333.33 %) |
| Mar 07 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 60.01 | 3,068 | 184,111 | 239,215 | 242.3 K to 239.2 K (-1.27 %) |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 5,300 | 189,740 | 41,250 | |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 54.05 | 5,300 | 286,465 | 39,500 | 44.8 K to 39.5 K (-11.83 %) |
| Feb 27 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 5,300 | 189,740 | 44,800 | 39.5 K to 44.8 K (+13.42 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 15,000 | 12,750 | 174,670 | |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.84 | 8,066 | 385,877 | 246,000 | 254.1 K to 246 K (-3.17 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.30 | 3,522 | 166,591 | 254,066 | 257.6 K to 254.1 K (-1.37 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 45.96 | 3,412 | 156,816 | 257,588 | 261 K to 257.6 K (-1.31 %) |
| Feb 19 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 15,000 | 12,750 | 261,000 | 246 K to 261 K (+6.10 %) |
| Feb 11 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 120,000 | 102,000 | 84,900 | |
| Feb 11 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 120,000 | 102,000 | 242,283 | 122.3 K to 242.3 K (+98.13 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 13.09 | 625 | 8,181 | 2,708 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 19.50 | 1,875 | 36,563 | 15,000 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 43,219 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | M | 35.80 | 8,450 | 302,510 | 46,550 | |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Sell | S | 50.08 | 43,832 | 2,195,107 | 39,500 | 83.3 K to 39.5 K (-52.60 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 13.09 | 625 | 8,181 | 83,332 | 82.7 K to 83.3 K (+0.76 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 19.50 | 1,875 | 36,563 | 82,707 | 80.8 K to 82.7 K (+2.32 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 22.00 | 32,882 | 723,404 | 80,832 | 48 K to 80.8 K (+68.58 %) |
| Feb 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Buy | M | 35.80 | 8,450 | 302,510 | 47,950 | 39.5 K to 48 K (+21.39 %) |
| Feb 05 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 45,000 | 38,250 | 189,670 | |
| Feb 05 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 45,000 | 38,250 | 246,000 | 201 K to 246 K (+22.39 %) |
| Jan 17 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 44.40 | 3,140 | 139,416 | 201,000 | 204.1 K to 201 K (-1.54 %) |
| Jan 17 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 43.70 | 11,860 | 518,282 | 204,140 | 216 K to 204.1 K (-5.49 %) |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | A | 40.82 | 45,000 | 1,836,900 | 45,000 | |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Grant | A | 35.66 | 337 | 12,017 | 3,006 | 2.7 K to 3 K (+12.63 %) |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Product Develo ... | Option Exercise | A | 40.82 | 46,000 | 1,877,720 | 46,000 | |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | A | 40.82 | 48,000 | 1,959,360 | 48,000 | |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | A | 40.82 | 57,000 | 2,326,740 | 57,000 | |
| Jan 07 2019 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | A | 40.82 | 190,000 | 7,755,800 | 190,000 | |
| Dec 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 53,472 | |
| Dec 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 48.97 | 720 | 35,258 | 2,669 | 3.4 K to 2.7 K (-21.25 %) |
| Dec 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 47.85 | 2,055 | 98,332 | 3,389 | 5.4 K to 3.4 K (-37.75 %) |
| Dec 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 46.79 | 2,225 | 104,108 | 5,444 | 7.7 K to 5.4 K (-29.01 %) |
| Dec 20 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 7,669 | 2.7 K to 7.7 K (+187.34 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 47.74 | 1,700 | 81,158 | 122,283 | 124 K to 122.3 K (-1.37 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 46.47 | 1,700 | 78,999 | 123,983 | 125.7 K to 124 K (-1.35 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 45.73 | 4,100 | 187,493 | 125,683 | 129.8 K to 125.7 K (-3.16 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 47.74 | 4,408 | 210,438 | 216,000 | 220.4 K to 216 K (-2.00 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 46.81 | 2,988 | 139,868 | 220,408 | 223.4 K to 220.4 K (-1.34 %) |
| Dec 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 46.11 | 7,604 | 350,620 | 223,396 | 231 K to 223.4 K (-3.29 %) |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 40,830 | |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.20 | 507 | 31,028 | 0 | 507 to 0 (-100.00 %) |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.35 | 13,053 | 787,749 | 507 | 13.6 K to 507 (-96.26 %) |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.62 | 6,854 | 408,635 | 13,560 | 20.4 K to 13.6 K (-33.57 %) |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.33 | 1,300 | 79,729 | 231,000 | 232.3 K to 231 K (-0.56 %) |
| Dec 06 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 60.34 | 18,700 | 1,128,358 | 232,300 | 251 K to 232.3 K (-7.45 %) |
| Dec 04 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 1,500 | 30,525 | 78,500 | |
| Dec 04 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 1,500 | 30,525 | 1,500 | 0 to 1.5 K |
| Dec 03 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 3.76 | 12,784 | 48,068 | 53,000 | ||
| Dec 03 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 65.00 | 12,784 | 830,960 | 0 | 12.8 K to 0 (-100.00 %) | |
| Dec 03 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 3.76 | 12,784 | 48,068 | 12,784 | 0 to 12.8 K | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 3.76 | 716 | 2,692 | 65,784 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 6,250 | 79,625 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 18.85 | 6,250 | 117,813 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 22.00 | 4,687 | 103,114 | 0 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 883 | 43,664 | 7,292 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 1,721 | 85,103 | 8,175 | ||
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 65.03 | 18,786 | 1,221,654 | 0 | 18.8 K to 0 (-100.00 %) |